The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Olesya L IlkunTom GreeneAlfred K CheungPaul K WheltonGuo WeiRobert E BoucherWalter AmbrosiusGlenn M ChertowSrinivasan BeddhuPublished in: Diabetes care (2020)
In persons with T2DM, intensive SBP lowering decreased the risk of cardiovascular composite end point irrespective of baseline DBP in the setting of standard glycemic control. Hence, low baseline DBP should not be an impediment to intensive SBP lowering in patients with T2DM treated with guideline-recommended standard glycemic control.